Nepal recently announced that the second phase of its coronavirus vaccination campaign would begin on Wednesday, using a China-made Vero cell vaccine manufactured by the Beijing Institute of Biological Products in February this year.
Nepal has granted emergency approval for the Chinese Vero Cell Vaccine on Monday with 277,944 active cassioled, while 273,240 people have been recovered in Nepal.
On March 29, a batch of Chinese Kovid-19 vaccines developed by Sinopharm were flown to Nepal.
On Sunday, Nepal’s Ministry of Health and Population announced that it indicated that at least 4,00,000 people would be initially vaccinated using Chinese medicine for Kovid-19.
A spokesman for the Ministry of Health, Drs. Jageshwar Gautam stated, “500,000 Kovid vaccines have already received vaccines out of a total of 900,000 targeted for vaccination. These 800,000 doses of China-donated vaccines will be given to the remaining 400,000 people. About the target group, ”he elaborated in a press talk.
“They are involved in essential services, students studying in China under Chinese government scholarship, but currently stuck in Nepal due to the epidemic, with Nepali students leaving China for higher studies and in cross-border trade between Nepal and China There will be preparation for those involved. ” The vaccine should be vaccinated with the Chinese vaccine. ”
Meanwhile, Nepal reported 176 new Kovid cases on Monday. In early March, cases went below 50 per day. According to the Ministry of Health and Population, Nepal has so far vaccinated over 1.7 million people in two phases.